Supplementary Figures
. Scheme S1. Chemical formula for CBZ (1) and its metabolites after enzymatic degradation (2-5).
Scanning electron microscopy (SEM). Figure S3 . FTIR spectra of the sol gel HRP (a) and sol gel LiP (b) comsposite samples and enzymefree sol-gel silica (c). It has to be noted that the spectra are identical, showing only characteristic bands of sol-gel silica:.
Assignments for FTIR below. . Figure S11 . Representative image of a peak force curve for the pristine iron oxide particles.
. Figure S12 . Representative image of a peak force curve for the LiP coated iron oxide particle.
Figure S13. Representative image of a peak force curve for the silica-coated LiP-bearing iron oxide particles. 
Drugs degradation by non-encapsulated enzymes.
Experiments were done with-and without enzymes; experiments were multiplicated and ran in a few cycles. . Figure S15 . Paracetamol degradation non-encapsulated HRP, pH=7 (t=18 h, C=1 mg/ml). . Figure S16 . Diclofenac degradation non-encapsulated HRP, pH=7 (t=19h40 min, C=1mg/ml).
Enzyme leaching from sol gel encapsulated composites.
Enzyme leakage tests, were performed using both UV-Vis at λ = 280 nm to detect enzyme, and to evaluate possible enzymatic activity of leachate (ABTS, λ = 420 nm). Tests were performed as following. 30 mg of sample has been shaking at 55 °C for 24 h in deionized water. After composite decantation by magnet, solutions were filtered through 200 µ m membrane filter and measured by UV-Vis at λ = 280 nm. Then, ABTS was added and solution was kept for 24 h at 55 °C to react. Activity was measured at λ = 420 nm. In total, 12 measurements were done. Data is shown below.
Normalized optical density shown in negative values for better representation. 
